CSAB3 Stock Overview
Companhia de Seguros Alianca da Bahia operates as an insurance company in Brazil and Uruguay. More details
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 1/6 |
Companhia de Seguros Alianca da Bahia Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | R$30.50 |
52 Week High | R$35.01 |
52 Week Low | R$26.51 |
Beta | 0.18 |
11 Month Change | -12.86% |
3 Month Change | n/a |
1 Year Change | n/a |
33 Year Change | -37.86% |
5 Year Change | -33.70% |
Change since IPO | 100,953.61% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
CSAB3 | BR Insurance | BR Market | |
---|---|---|---|
7D | 0% | -0.4% | -0.8% |
1Y | n/a | 16.8% | -2.4% |
Return vs Industry: Insufficient data to determine how CSAB3 performed against the BR Insurance industry.
Return vs Market: Insufficient data to determine how CSAB3 performed against the BR Market.
Price Volatility
CSAB3 volatility | |
---|---|
CSAB3 Average Weekly Movement | n/a |
Insurance Industry Average Movement | 3.0% |
Market Average Movement | 4.6% |
10% most volatile stocks in BR Market | 8.2% |
10% least volatile stocks in BR Market | 2.4% |
Stable Share Price: CSAB3 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CSAB3's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1870 | n/a | José de Almeida Gonçalves Tourinho | www.alba.com.br |
Companhia de Seguros Alianca da Bahia operates as an insurance company in Brazil and Uruguay. The company offers life, personal accident, credit life, residential, business, sundry risk, extended warranty, and operational risk insurance products. Companhia de Seguros Alianca da Bahia was founded in 1870 and is headquartered in Salvador, Brazil.
Companhia de Seguros Alianca da Bahia Fundamentals Summary
CSAB3 fundamental statistics | |
---|---|
Market cap | R$305.16m |
Earnings (TTM) | R$16.24m |
Revenue (TTM) | R$3.97m |
23.2x
P/E Ratio94.8x
P/S RatioIs CSAB3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CSAB3 income statement (TTM) | |
---|---|
Revenue | R$3.97m |
Cost of Revenue | R$1.78m |
Gross Profit | R$2.19m |
Other Expenses | -R$14.05m |
Earnings | R$16.24m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 2.11 |
Gross Margin | 55.08% |
Net Profit Margin | 409.10% |
Debt/Equity Ratio | 0% |
How did CSAB3 perform over the long term?
See historical performance and comparison